Corcept Therapeutics Inc., of Menlo Park, Calif., reported a third quarter GAAP net loss of $600,000, down from $6 million in the third quarter of 2014. Non-GAAP net income for the period increased to $1.6 million, compared to a non-GAAP net loss of $3.9 million in the third quarter of 2014.